Atherosclerosis segments with high unmet medical needs such as: acute coronary syndrome, atherosclerosis in diabetics, statin intolerant, chronic kidney disease, and peripheral arterial disease.
Hypertension segments with high unmet medical needs, such as systolic hypertension, resistant hypertension, hypertension associated with diabetes, hypertension with chronic kidney disease, and pulmonary hypertension. Heart failure, in particular heart failure with preserved ejection fraction, is also of interest.
We are interested in novel mechanisms for the treatment and prevention of arterial and venous thrombotic events.
We will continue to pursue external licensing and partnership opportunities for differentiated products in all disease areas in late-stage development (Phase III-ready and later). In addition to those areas cited above, we are particularly interested in antiarrhythmic agents for atrial fibrillation.
If you think something you discovered might be of interest to Merck, contact one of our scientific scouts.